1 RISK SHARING FINANCE FACILITY Research Connection 2009 Prague 8 May 2009 Anna Krzyzanowska.
-
Upload
nathan-maldonado -
Category
Documents
-
view
217 -
download
3
Transcript of 1 RISK SHARING FINANCE FACILITY Research Connection 2009 Prague 8 May 2009 Anna Krzyzanowska.
1
RISK SHARING FINANCE FACILITY Research Connection 2009
Prague 8 May 2009
Anna Krzyzanowska
2
Risk-Sharing Finance Facility (RSFF)
Introduction
3
651.4China753.3Japan642.6US551.8EU-27
R&D funded by private sector (%)R&D investment (%GDP)
651.4China753.3Japan642.6US551.8EU-27
R&D funded by private sector (%)R&D investment (%GDP)
EU-27
Russia
US
Japan
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
2000 2001 2002 2003 2004 2005 2006
R&D intensity (%GDP) China
EU hampered by low private sector investments
4
Risk-Sharing Finance Facility (RSFF):
The investment and financing gap• Despite increased FP 7 budget for 2007 – 2013 (EUR 54,6 billion), there is a lack of funding for excellent and top quality R&D projects at EU level
• Investment in R&D is crucial for Europe’s competitiveness and growth potential
• Lack of private investment in R&D has been identified as the single key factor for Europe’s relatively weak total investment in R & D
• R&D investment carries a high(er) risk and uncertainty; scarce financing resources in Europe for such risky projects (market deficiency)
5
• December 2005 European Council:
“The European Council invites the Commission in cooperation with the European Investment Bank (EIB) to examine the possibility of strengthening their support for Research and Development by up to a maximum of EUR 10 billion through a financing facility with risk‑sharing components to foster additional investment in European research and development, particularly by the private sector.”
A political request to increase financial support to R&D
6
Risk-Sharing Finance Facility Added value
An innovative financing mechanism to:• Foster increased private investment in research by improving
access to loan finance.• Risk-sharing between the Community and EIB to allow:
- Larger volume of risky lending to R&D
- Financing of riskier, but creditworthy projects• Generate a leverage effect so that the volume of extra lending
by EIB and its partner banks is a 4 to 6 multiple of the Community funds provided to the facility.
• Rely on an existing EIB facility (SFF), and therefore benefit from EIB’ s experience and management.
7
Risk-Sharing Finance Facility (RSFF)
Implementation Strategy
8
RSFF implementation strategyRisk categories
RSFF Risk Coverage Range
Moody's S&P and Fitch… …A1 A+A2 AA3 A-
Baa1 BBB+Baa2 BBBBaa3 BBB-Ba1 BB+Ba2 BBBa3 BB-B1 B+B2 BB3 B-
•RSFF is a debt based instrument not a grant
•Financing does not involve a subsidy element
•The facility does not concern risk capital such as venture capital
RSFF concerns companies or projects mature enough to demonstrate capacity to repay and service debt on the basis of a credible business plan.An external rating is not required.
9
RSFF implementation strategyEligible project cost
Project capital expenditures in tangible assets.
Intangible assets:
Research staff cost
Incremental working capital requirements
Acquisition of Intellectual Property Rights
Multi-annual R&D budgets (typically 3-4 years)Financing up to 50% of total cost, except particular cases in line with EIB strategic orientations (ie: environment, renewable
energies; …)
10
RSFF implementation strategyBeneficiaries of RSFF financing
Mid-Caps and large corporates (typically unrated / sub investment grade / turnaround situations)
SMEs
Research Institutes
Universities
Special Purpose / Project Companies
Research Infrastructure promoters
Any size and ownership
11
Indirect loans / guarantees
Commercial bank
Beneficiary (promoter)
Refinancing/Guarantee
Loan
Direct loans / guarantees
Comm. bank(Co-finance)
Borrower (promoter)
Loan or Guarantee
RSFF implementation strategy Financing modes – individual financing
Loan
Guarantee
12
Risk-Sharing Finance Facility (RSFF)
An approch to smaller projects
13
SMEs: Complementarities between CIP and FP7 (RSFF)
Risk Capital1 CIP Resources (SME)2 RSFF (SME / MidCap)3
Entrepreneur, friends, family
Business Angels
Seed/Early Stage VC Funds
Formal VC Funds
Bank Loans and Guarantees
Seed / Start-Up Phase Emerging Growth Phase Development Phase
Facility: High Growth Innovative SME Scheme (GIF), Ecotech
Purpose: IP financing, technology transfer, seed financing, investment readiness
Target Group: VC Funds, Business Angels
EIF Product: Fund-of-Funds
Facility: CIP Guarantee schemes
Purpose: Growth financing for SMEs
Target Group: Formal VC Funds, CLOs
EIF Product: SME guarantees (loans, microcredit, equity/mezzanine, securitisation
Facility: RSFF
Purpose: RDI financing
Target Group: SMEs/MidCaps, Banks, PE Investors,
EIB Product: Loans (incl. Mezzanine), Funded Risk Sharing Facilities with Banks (Investors)
14
EIB
BorrowerEIB
For loans of EUR 7.5 million or more - direct involvement by the EIB
BorrowerIntermediary
For all loans where borrowers wish to work with their own banks, in particular those of less than EUR 7.5 million - sharing of RSFF benefitswith intermediaries (e.g. through partial guarantees)
Refinancing/ Guarantee
EIB and its partner banks (intermediaries)
15
Risk-Sharing Finance Facility (RSFF)
Results to date
16
RSFF results and portfolio
Volumes: EUR 2.4 billion authorised by the EIB under RSFF by February 2009, of which 1.488 billion have already been signed (under EC window: 48 %, EIB window 52 %)
Main sectors financed so far: renewable energy technologies, engineering and automotive, life science and ICT, plus risk-sharing facilities with partner banks
Geographical spread: projects located in 14 countries by early 2009 (approved RSFF projects)
RSFF financing in the form of direct corporate loans, project finance to special purpose vehicles and risk-sharing arrangements for mid-cap / SME projects
17
RSFF portfolioGeographical Spread – signatures until 30/11/2008
18
And the crisis in all this?
• The current market sentiment:– (i) significant increases in credit spreads, – (ii) sharp decline in commercial bank financing supply due to funding
as well as capital constraints of banks in the market and – (iii) decreasing RDI investments due to expected economic down-
turn.
• The implications for RSFF are both positive (more projects) and negative (high mortality rate
• Market/business risk profiles increased significantly hence an increase in credit risk for new transactions but also for existing RSFF loan exposures.
• Execution time for new operations is expected to increase and sophisticated financial structuring to mitigate operational risks more and more important
19
SMEs/Mid Cap – Facility StructuresApproved
Signature of the Automotive Supplier RDI Facility (loans and guarantees to RDI projects of SMEs and mid cap automotive suppliers in Germany; EUR 100m + EUR 50m) - RSFF
Approval of KfW Ipex Risk Sharing Facility (loans and guarantees to mid-cap companies in Germany; EUR 100m + EUR 50m) - RSFF
Approval of RZB Group Risk Sharing Facility (loans and guarantees to mid cap companies in Austria, Hungary, Romania; EUR 100m + EUR 70m) – partially RSFF
Approval of CS Risk Sharing Energy Efficiency (loans and guarantees to SMEs in the Czech Republic; EUR 100m + EUR 60m) – SMEs, non RSFF
20
Risk-Sharing Finance Facility (RSFF)
Examples
21
Solucar Solar Thermal Power project : Europe's first commercially operating power station using the sun's energy, in west of Seville (Spain)
€50-million RSFF loan to further develop a large scale application of Concentrating Solar Power (CSP) technology, generating electricity without greenhouse-gas emissions
Field of mirrors to concentrate solar radiation on a thermal receiver
www.solucar.es
Financing solar power
using indigenous renewable energy to contribute to combat climate change
22
PharmaMar: Spain’s leading biotech company dedicated to developing innovative anticancer treatments from marine origin
Biopharmaceutical research & development in the areas ofoncology and orphan diseases Different forms of cancer targetted, including rare cancers 30-million RSFF loan
www.pharmamar.com
Innovative anticancer treatments helping bring 4 cancer drugs to the market
23
AVL: Austrian family-owned specialist with strong reputation for producing fuel-saving technologies for powertrain systems
Offers research and development support to many major car manufacturers worldwide.
€30-million RSFF loan to help AVL extend powertrain R&Dand research in the areas of hydrogen fuel-cell technology, nanocomposites and engine technologies
www.avl.com
Cleaner engines improving energy efficiency
24
Risk-Sharing Finance Facility (RSFF)
Information & contacts
25
RSFF contact pointsEuropean Commission, DG RTD
Directorate B – « European Research Area: Research programmes and capacities »
Unit B.04 – « Regions of Knowledge and Research Potential »
– RSFF Sector
• Jean-David MALO, Head of Unit, (02 299 38 42)
• Martin KOCH
• Marie-Cécile ROUILLON
26
RSFF contact pointsEuropean Investment Bank
Directorate for Operations in the European Union and Candidate Countries
Division: Action for Growth Instruments – Innovation 2010 Initiative (i2i)
• Heinz OLBERS• Pavla RANDOVA : + 352 4379 7307
– http://www.eib.org/rsff
27
Thank you for your attention